Moderna is eying a price of $110 to $130 per COVID-19 vaccine dose when its supply deals with the U.S. government end, The Wall Street Journal (WSJ) reports.
Moderna, like its vaccine competitor Pfizer, is considering a higher commercial price for its two-shot mRNA vaccine, CEO Stéphane Bancel told the WSJ at the J.P. Morgan Healthcare Conference in San Fransisco.
“I would think this type of pricing is consistent with the value,” said Bancel, according to the WSJ report.
The Massachusetts-based drugmaker is reportedly considering a huge price increase. By contrast, the price the U.S. government paid for public contracts ranged from $15.25 to $17.5 per dose….